MoneyWorks4Me

Lupin informs about press release

01 Apr 2019 Evaluate

Lupin has informed that it has enclosed a Press Release as regards launch of Tadalafil Tablets USP, 2.5 mg, 5 mg, 10 mg, and 20 mg for which US FDA approval was received earlier. This is considered as a disclosure pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations. 2015.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1810.00
Dr. Reddys Labs. 1200.10
Cipla 1346.85
Lupin 2029.00
Zydus Lifesciences 1145.25
View more..